Quotient (NASDAQ:QTNT) Stock Rating Upgraded by Zacks Invest

Quotient (NASDAQ:QTNT – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report released on Wednesday, Zacks.com reports. According to Zacks, “Quotient Limited is a commercial-stage transfusion diagnostics company. It is focused on supplying blood-grouping consumables and developing MosaiQ, a fully automated platform for use in […]

Related Keywords

Pennsylvania , United States , Japan , United Kingdom , France , Texas , Edinburgh , City Of , Scotland , Thomson Reuter , Financial Services Group Inc , Quotient Company Profile Get Rating , Cubist Systematic Strategies , Zacks Investment Research , Balyasny Asset Management , Citigroup Inc , Get Rating , Director Prondzynski Heino Von , Services Group , Asset Management , Retirement System , Company Profile , Quotient , Nasdaq Qtnt , Qtnt , Medical , Upgrade ,